Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma

Journal of Steroid Biochemistry and Molecular Biology

Volumn 107, Issue 1-2, 2007, Pages 37-41

  Morales, Angélica ^a   Vilchis, Felipe ^a   Chávez, Bertha ^a   Chan, Carlos ^a   Robles Díaz, Guillermo ^b   Díaz Sánchez, Vicente ^c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c MEXFAM AC Juárez ^*  (Mexico)

Author keywords

Dimorphic pattern; Endocrine gland derived vascular endothelial growth factor (EG VEGF); Endothelial cells; Normal human pancreas; Pancreatic adenocarcinoma; Prokineticin 1 (PROK 1); Steroidogenic factor (SF 1)

Indexed keywords

ANGIOGENIC FACTOR; GENE PRODUCT; MESSENGER RNA; MITOGENIC AGENT; VASCULOTROPIN;

ANTIBODY LABELING; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCRINE GLAND; ENDOTHELIUM CELL; FEMALE; GENDER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS; TISSUE SPECIFICITY; VASCULAR ENDOTHELIUM;

ADENOCARCINOMA; FEMALE; GASTROINTESTINAL HORMONES; HUMANS; MALE; PANCREAS; PANCREATIC NEOPLASMS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 34548432592     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.02.006     Document Type: Article

References (30)

1. Kaser A., Winklmayr M., Lepperdinger G., and Kreil G. The AVIT protein family-secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep. 4 (2003) 469-473
2. Ferrara N., LeCouter J., Rui L., and Peale F. EG-VEGF and Bv8: a novel family of tissue restricted angiogenic factors. Biotech. Biophys. Acta 1654 (2004) 69-78
3. Lin D.C., Bullock C.M., Ehlert F.J., Chen J.L., Tian H., and Zhou Q.Y. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J. Biol. Chem. 277 (2002) 19276-19280
4. Soga T., Matsumoto S., Oda T., Saito T., Hiyama H., Takasaki J., Kamohara M., Ohishi T., Matsushime H., and Furuichi K. Molecular cloning and characterization of prokineticin receptors. Biochim. Biophys. Acta 1579 (2002) 173-179
5. Li M., Bullock C.M., Knauer D.J., Ehlert F.J., and Zhou Q.Y. Identification of two prokineticin cDNAs recombinant proteins potently contract gastrointestinal smooth muscle. Mol. Pharmacol. 59 (2001) 692-698
6. LeCouter J., Rui L., and Ferrara N. EG-VEGF: a novel mediator of endocrine-specific angiogenesis, endothelial phenotype and function. Ann. N.Y. Acad. Sci. 1014 (2004) 50-57
7. Dorsch M., Qiu Y.B., Soler D., Frank N., Duong T., Goodearl A., O'Neil S., Lora J., and Fraser C.C. PKI/EG-VEGF induces monocyte differentiation and activation. J. Leukoc. Biol. 78 (2005) 426-434
8. Bakke M., Zhao L.P., Hanley N.A., and Parker K.L. SF-1: a critical mediator of steroidogenesis. Mol. Cell Endocrinol. 171 (2001) 5-7
9. Bakker M., Zhao L.P., and Parker K.L. Approaches to define the role of SF-1 at different levels of the hypothalamic-pituitary steroidogenic organ axis. Mol. Cell Endocrinol. 179 (2001) 33-37
10. Morohashi K.I. Gonadal and extragonadal functions of Ad4BP/SF-1: developmental aspects. TEM 10 (1999) 169-173
11. Hanley N.A., Ball S.G., Clement-Jones M., Hagan D.M., Strachan T., Lindsay S., Robson S., Ostrer H., Parker K.L., and Wilson D.I. Steroidogenic factor 1: an essential mediator of endocrine development. Rec. Prog. Horm. Res. 57 (2002) 19-36
12. Ozisik G., Achermann J.C., Meeks J.J., and Jameson J.L. SF-1 in the development of the adrenal and gonads. Horm. Res. 59 (2003) 94-98
13. Morales A., Vilchis F., Chávez B., Chan C., Robles-Díaz G., and Díaz-Sánchez V. Expression of steroidogenic factors 1 and 2 in normal human pancreas. J. Steroid Biochem. Mol. Biol. 98 (2006) 254-258
14. Christofori G., Naik P., and Hanahan D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol. Endocrinol. 9 (1995) 1760-1770
15. LeCouter J., Kowalski J., Foster J., Hass P., Zhang Z., Dillard-Telm L., Frantz G., Rangell L., DeGuszman L., Keller G.-A., Peale F., Gurney A., Hillan K.J., and Ferrara N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412 (2001) 877-884
16. Montgomery D.C. Design and Analysis of Experiments (1997), John Wiley & Sons, Arizona State University, New York
17. Chang K.J., Parasher G., Chritie C., Langent L., and Aton-Culver H. Risk of pancreatic adenocarcinoma disparity between African Americans and other race/ethnic groups. Cancer 103 (2005) 349-357
18. Grapin-Botton A. Ductal cells of the pancreas. Int. J. Biochem. Cell Biol. 37 (2005) 504-510
19. Fesinmeyer M.D., Austin M.A., Li C., De Roos A.J., and Bowen D.J. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1766-1773
20. Lygidakis N.J., Jain S., Sacchi M., and Vrachnos P. Adenocarcinoma of the pancreas-past, present and future. Hepatogastroenterology 52 (2005) 1281-1292
21. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
22. Hirozumi S., Yuji O., Hitoshi F., Yoichi M., Hiroki T., Hiromitsu T., and Tadao M. Interleukin-1α enhances the aggressive behavior of pancreatic cancer cells by regulating the α6β1-integrin and urokinase plasminogen activator receptor expression. BMC Cell Biol. 7 8 (2006) 1-13
23. Reinmuth N., Parikh A.A., Ahmad S.A., Liu W., Stoeltzing O., Fan F., Takeda A., Akagi M., and Ellis L.M. Biology of angiogenesis in tumors of the gastrointestinal tract. Microsc. Res. Tech. 60 (2003) 199-207
24. La Rosa S., Uccella S., Finzi L., Albarello L., Sessa F., and Capella C. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors correlation with microvessel density and clinicopathologic features. Hum. Pathol. 34 (2003) 18-27
25. Díaz-Sánchez V., Morimoto S., Morales A., Robles-Díaz G., and Cerbón M. Androgen receptor in the rat pancreas genetic expression and steroid regulation. Pancreas 11 (1994) 241-245
26. Morales A., Cuellar A., Ramírez J., Vilchis F., and Díaz-Sánchez V. Synthesis of steroids in pancreas: evidence of cytochrome P-450scc activity. Pancreas 19 (1999) 39-44
27. Morales A., Duarte-Rojo A., Ángeles-Ángeles A., Robles-Díaz G., and Díaz-Sánchez V. The beta form of the estrogen receptor is predominantly expressed in the papillary cystic neoplasm of the pancreas. Pancreas 26 (2003) 258-263
28. Dieddonne M.N., Sammari A., Dos Santos E., Leneveu M.C., Giudicelli Y., and Pecquery R. Sex steroids and leptin regulate 11 beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J. Steroid Biochem. Mol. Biol. 99 (2006) 189-196
29. Tuner E.H., Harris L.A., Melmed S., and Wass A.H. Angiogenesis in endocrine tumors. Endocr. Rev. 24 (2003) 600-632
30. LeCouter J., Lin R., and Ferrara N. Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis. Nat. Med. 8 (2002) 913-917